Vascular dementia

The Lancet

Volumn 386, Issue 10004, 2015, Pages 1698-1706

  O'Brien, John T ^a   Thomas, Alan ^b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Department of Neurology Institute of Neuroscience   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; HOMOCYSTEINE; MEMANTINE; METALLOPROTEINASE; NIMODIPINE; NITRENDIPINE; PRAVASTATIN; RIVASTIGMINE; SIMVASTATIN;

AGE; ALLELE; ALZHEIMER DISEASE; APATHY; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CHROMOSOME 19; CLINICAL FEATURE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DELUSION; DIABETES MELLITUS; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FRAMESHIFT MUTATION; FUNCTIONAL DISEASE; GENDER; GENETIC ASSOCIATION; HALLUCINATION; HIPPOCAMPAL SCLEROSIS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LATE LIFE DEPRESSION; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; MULTIINFARCT DEMENTIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; WHITE MATTER LESION; X CHROMOSOME; DEMENTIA, VASCULAR; DIAGNOSTIC IMAGING; GENETICS;

DEMENTIA, VASCULAR; DIAGNOSTIC IMAGING; HUMANS; RISK FACTORS;

EID: 84945350874     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00463-8     Document Type: Review

References (84)

1. G Blessed, BE Tomlinson, M Roth The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects Br J Psychiatry 114 1968 797 811
2. VC Hachinski, NA Lassen, J Marshall Multi-infarct dementia. A cause of mental deterioration in the elderly Lancet 2 1974 207 210
3. World Health Organization The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines 1992 World Health Organization Geneva
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV 1994 American Psychiatric Association Washington, DC
5. GC Román, T Erkinjuntti, A Wallin, L Pantoni, HC Chui Subcortical ischaemic vascular dementia Lancet Neurol 1 2002 426 436
6. GC Román, TK Tatemichi, T Erkinjuntti et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop Neurology 43 1993 250 260
7. HC Chui, JI Victoroff, D Margolin, W Jagust, R Shankle, R Katzman Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers Neurology 42 1992 473 480
8. T Erkinjuntti, D Inzitari, L Pantoni et al. Research criteria for subcortical vascular dementia in clinical trials J Neural Transm Suppl 59 2000 23 30
9. G Gold, C Bouras, A Canuto et al. Clinicopathological validation study of four sets of clinical criteria for vascular dementia Am J Psychiatry 159 2002 82 87
10. JT O'Brien, T Erkinjuntti, B Reisberg et al. Vascular cognitive impairment Lancet Neurol 2 2003 89 98
11. V Hachinski, C Iadecola, RC Petersen et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards Stroke 37 2006 2220 2241
12. MU Farooq, PB Gorelick Vascular cognitive impairment Curr Atheroscler Rep 15 2013 330
13. RC Petersen, J O'Brien Mild cognitive impairment should be considered for DSM-V J Geriatr Psychiatry Neurol 19 2006 147 154
14. P Sachdev, R Kalaria, J O'Brien the Internationlal Society for Vascular Behavioral and Cognitive Disorders Diagnostic criteria for vascular cognitive disorders: a VASCOG statement Alzheimer Dis Assoc Disord 28 2014 206 218
15. AF Jorm, D Jolley The incidence of dementia: a meta-analysis Neurology 51 1998 728 733
16. ST Pendlebury, PM Rothwell Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis Lancet Neurol 8 2009 1006 1018
17. LM Allan, EN Rowan, MJ Firbank et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors Brain 134 2011 3716 3727
18. M Wiesmann, AJ Kiliaan, JAHR Claassen Vascular aspects of cognitive impairment and dementia J Cereb Blood Flow Metab 33 2013 1696 1706
19. BS Diniz, MA Butters, SM Albert, MA Dew, CF Reynolds 3rd Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies Br J Psychiatry 202 2013 329 335
20. A Teodorczuk, JT O'Brien, MJ Firbank the LADIS Group White matter changes and late-life depressive symptoms: longitudinal study Br J Psychiatry 191 2007 212 217
21. MJ Firbank, A Teodorczuk, WM van der Flier the LADIS group Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study Br J Psychiatry 201 2012 40 45
22. AJ Thomas, JT O'Brien, S Davis et al. Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study Arch Gen Psychiatry 59 2002 785 792
23. AJ Thomas, RN Kalaria, JT O'Brien Depression and vascular disease: what is the relationship? J Affect Disord 79 2004 81 95
24. RFAG de Bruijn, MA Ikram Cardiovascular risk factors and future risk of Alzheimer's disease BMC Med 12 2014 130
25. DA Snowdon, LH Greiner, JA Mortimer, KP Riley, PA Greiner, WR Markesbery Brain infarction and the clinical expression of Alzheimer disease. The Nun Study JAMA 277 1997 813 817
26. KA Jellinger, J Attems Challenges of multimorbidity of the aging brain: a critical update J Neural Transm 122 2015 505 521
27. GT Stebbins, DL Nyenhuis, C Wang et al. Gray matter atrophy in patients with ischemic stroke with cognitive impairment Stroke 39 2008 785 793
28. MF Folstein, SE Folstein, PR McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
29. R Lees, J Selvarajah, C Fenton et al. Test accuracy of cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke Stroke 45 2014 3008 3018
30. R Ylikoski, H Jokinen, P Andersen the LADIS Study Group Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study Dement Geriatr Cogn Disord 24 2007 73 81
31. CG Lyketsos, O Lopez, B Jones, AL Fitzpatrick, J Breitner, S DeKosky Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study JAMA 288 2002 1475 1483
32. M Gupta, A Dasgupta Behavioural and psychological symptoms in poststroke vascular cognitive impairment Behav Neurol 2014 2014 430128
33. EH Kua, E Ho, HH Tan, C Tsoi, C Thng, R Mahendran The natural history of dementia Psychogeriatrics 14 2014 196 201
34. CG Ballard, EJ Burton, R Barber et al. NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia Neurology 63 2004 983 988
35. CC Price, AL Jefferson, JG Merino, KM Heilman, DJ Libon Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data Neurology 65 2005 376 382
36. D Inzitari, G Pracucci, A Poggesi the LADIS Study Group Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort BMJ 339 2009 b2477
37. G Fein, V Di Sclafani, J Tanabe et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease Neurology 55 2000 1626 1635
38. C Zarow, L Wang, HC Chui, MW Weiner, JG Csernansky MRI shows more severe hippocampal atrophy and shape deformation in hippocampal sclerosis than in Alzheimer's disease Int J Alzheimers Dis 2011 2011 483972
39. K Herholz, K Ebmeier Clinical amyloid imaging in Alzheimer's disease Lancet Neurol 10 2011 667 670
40. N Mattsson, H Zetterberg, O Hansson et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment JAMA 302 2009 385 393
41. A Jagtap, S Gawande, S Sharma Biomarkers in vascular dementia: A recent update Biomarkers Genomic Med 7 2014 43 56
42. H Chabriat, A Joutel, M Dichgans, E Tournier-Lasserve, M-G Bousser Cadasil Lancet Neurol 8 2009 643 653
43. EMC Schrijvers, B Schürmann, PJ Koudstaal et al. Genome-wide association study of vascular dementia Stroke 43 2012 315 319
44. R Dwyer, OA Skrobot, J Dwyer, M Munafo, PG Kehoe Using Alzgene-like approaches to investigate susceptibility genes for vascular cognitive impairment J Alzheimers Dis 34 2013 145 154
45. Y-W Yin, J-C Li, J-Z Wang et al. Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: a meta-analysis Neurosci Lett 514 2012 6 11
46. C Iadecola The pathobiology of vascular dementia Neuron 80 2013 844 866
47. H Liu, M Yang, G-M Li et al. The MTHFR C677T polymorphism contributes to an increased risk for vascular dementia: a meta-analysis J Neurol Sci 294 2010 74 80
48. RCM Ho, MWL Cheung, E Fu et al. Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression Am J Geriatr Psychiatry 19 2011 607 617
49. J-M Zhuo, H Wang, D Praticò Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol Sci 32 2011 562 571
50. J Flint, KS Kendler The genetics of major depression Neuron 81 2014 484 503
51. DR Thal, LT Grinberg, J Attems Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain Exp Gerontol 47 2012 816 824
52. LT Grinberg, H Heinsen Toward a pathological definition of vascular dementia J Neurol Sci 299 2010 136 138
53. V Deramecourt, JY Slade, AE Oakley et al. Staging and natural history of cerebrovascular pathology in dementia Neurology 78 2012 1043 1050
54. BCM Stephan, FE Matthews, B Ma et al. Alzheimer and vascular neuropathological changes associated with different cognitive States in a non-demented sample J Alzheimers Dis 29 2012 309 318
55. AM Brickman, KL Siedlecki, J Muraskin et al. White matter hyperintensities and cognition: testing the reserve hypothesis Neurobiol Aging 32 2011 1588 1598
56. KA Jellinger, J Attems Is there pure vascular dementia in old age? J Neurol Sci 299 2010 150 154
57. F Amenta, MA DiTullio, D Tomassoni The cholinergic approach for the treatment of vascular dementia: evidence from pre-clinical and clinical studies Clin Exp Hypertens 24 2002 697 713
58. E Perry, I Ziabreva, R Perry, D Aarsland, C Ballard Absence of cholinergic deficits in "pure" vascular dementia Neurology 64 2005 132 133
59. T Erkinjuntti, A Kurz, S Gauthier, R Bullock, S Lilienfeld, CV Damaraju Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial Lancet 359 2002 1283 1290
60. AP Auchus, HR Brashear, S Salloway, AD Korczyn, PP De Deyn, C Gassmann-Mayer the GAL-INT-26 Study Group Galantamine treatment of vascular dementia: a randomized trial Neurology 69 2007 448 458
61. S Black, GC Román, DS Geldmacher the Donepezil 307 Vascular Dementia Study Group Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial Stroke 34 2003 2323 2330
62. D Wilkinson, R Doody, R Helme the Donepezil 308 Study Group Donepezil in vascular dementia: a randomized, placebo-controlled study Neurology 61 2003 479 486
63. GC Román, S Salloway, SE Black et al. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size Stroke 41 2010 1213 1221
64. C Ballard, M Sauter, P Scheltens et al. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study Curr Med Res Opin 24 2008 2561 2574
65. National Collaborating Centre for Mental Health Dementia: supporting people with dementia and their carers in health and social care 2006 http://www.nice.org.uk/cg42
66. G Wilcock, HJ Möbius, A Stöffler the MMM 500 group A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500) Int Clin Psychopharmacol 17 2002 297 305
67. J-M Orgogozo, A-S Rigaud, A Stöffler, H-J Möbius, F Forette Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300) Stroke 33 2002 1834 1839
68. H Kavirajan, LS Schneider Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials Lancet Neurol 6 2007 782 792
69. L Pantoni, AM Basile, G Pracucci et al. Impact of age-related cerebral white matter changes on the transition to disability - the LADIS study: rationale, design and methodology Neuroepidemiology 24 2005 51 62
70. AB Guekht, H Moessler, PH Novak, EI Gusev Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial J Stroke Cerebrovasc Dis 20 2010 310 318
71. N Chen, M Yang, J Guo, M Zhou, C Zhu, L He Cerebrolysin for vascular dementia Cochrane Database Syst Rev 1 2013 CD008900.
72. J Shepherd, GJ Blauw, MB Murphy the PROSPER study group PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Lancet 360 2002 1623 1630
73. TD Rea, JC Breitner, BM Psaty et al. Statin use and the risk of incident dementia: the Cardiovascular Health Study Arch Neurol 62 2005 1047 1051
74. R Peters, N Beckett, F Forette the HYVET investigators Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial Lancet Neurol 7 2008 683 689
75. F Forette, ML Seux, JA Staessen et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial Lancet 352 1998 1347 1351
76. B McGuinness, S Todd, P Passmore, R Bullock Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia Cochrane Database Syst Rev 4 2009 CD004034.
77. LA Pearce, LA McClure, DC Anderson the SPS3 Investigators Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial Lancet Neurol 13 2014 1177 1185
78. JS Meyer, RL Rogers, K McClintic, KF Mortel, J Lotfi Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study J Am Geriatr Soc 37 1989 549 555
79. T Ngandu, J Lehtisalo, A Solomon et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial Lancet 385 2015 2255 2263
80. FE Matthews, A Arthur, LE Barnes the Medical Research Council Cognitive Function and Ageing Collaboration A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II Lancet 382 2013 1405 1412
81. PB Gorelick, A Scuteri, SE Black the American Heart Association Stroke Council Council on Epidemiology and Prevention Council on Cardiovascular Nursing Council on Cardiovascular Radiology and Intervention Council on Cardiovascular Surgery and Anesthesia Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association Stroke 42 2011 2672 2713
82. C Wentzel, K Rockwood, C MacKnight et al. Progression of impairment in patients with vascular cognitive impairment without dementia Neurology 57 2001 714 716
83. WT Longstreth Jr, C Bernick, TA Manolio, N Bryan, CA Jungreis, TR Price Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study Arch Neurol 55 1998 1217 1225
84. FE de Leeuw, JC de Groot, E Achten et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study J Neurol Neurosurg Psychiatry 70 2001 9 14